JENNIFER MARSH: Open Payments
NPI 1659740322 · SEVIERVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 15 payments from 9 companies in 2025. Trend: 2023 $1,052 · 2024 $440 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $94 |
| Novo Nordisk Inc | 2 | $53 |
| Boston Scientific Corporation | 1 | $33 |
| Astellas Pharma US Inc | 1 | $28 |
| Dynavax Technologies Corporation | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: CAPLYTA, Ozempic, WaveWriter Alpha Prime 16, Veozah, Heplisav-B, AIRSUPRA, TRELEGY ELLIPTA, VRAYLAR.
Industry payments across TN — which companies pay providers there.
